What is the theory behind use of BCAA enriched formulas in refractory encephalopathy?

• A. There is believed to be an increased ratio of aromatic amino acids and branched-chain amino acids in hepatic encephalopathy.
• B. Enteral formulas with higher amounts of BCAA and less AAA are available.
• C. Omega-3 fatty acids reduce ammonia production.
• D. Hepatic encephalopathy is caused by excessive AAAs alone.

Answer: (A)

The idea is that hepatic encephalopathy comes with an imbalance of amino acids in the blood: aromatic amino acids (like phenylalanine, tyrosine, tryptophan) rise relative to branched-chain amino acids (valine, leucine, isoleucine). This shift increases the amount of aromatic amino acids that cross into the brain, where they can disrupt neurotransmitter synthesis and contribute to encephalopathy. By using formulas enriched with branched-chain amino acids and lower in aromatic amino acids, you boost the competition for transport across the blood–brain barrier. This helps decrease brain uptake of aromatic amino acids, normalize neurotransmitter balance, and support protein synthesis and energy metabolism in the setting of liver failure.